Aptamers and aptazymes: accelerating small molecule drug discovery

Area of Science:

• Biotechnology
• Molecular Biology
• Drug Discovery

Background:

• Aptamers are synthetic nucleic acid ligands with high binding affinity.
• They show comparable or superior binding to monoclonal antibodies.
• Aptamer technology offers advantages in drug development.

Purpose of the Study:

• To highlight the utility of aptamers in modern drug development.
• To showcase aptamers as versatile tools for target identification and validation.
• To demonstrate aptamer applications in high-throughput screening.

Main Methods:

• Aptamers are generated rapidly and automatically against diverse target molecules.
• Nucleic acid probes can be structurally or chemically modified.
• RNA aptamers can be expressed transgenically or designed as biosensors.

Main Results:

• Aptamers function as detection probes, protein inhibitors, and competitors in screening assays.
• They enable multi-parallel proteome analysis and target prioritization.
• Aptamer technology accelerates small molecule lead identification.

Conclusions:

• Aptamer technology significantly enhances drug discovery efficiency.
• It provides a rapid, adaptable platform for developing novel therapeutic and diagnostic tools.
• The integration of aptamers with high-throughput screening expedites the drug discovery pipeline.